150 related articles for article (PubMed ID: 8097063)
21. Purine nucleotides induce regulated secretion of von Willebrand factor: involvement of cytosolic Ca2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis.
Vischer UM; Wollheim CB
Blood; 1998 Jan; 91(1):118-27. PubMed ID: 9414275
[TBL] [Abstract][Full Text] [Related]
22. Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth.
Renowden S; Edwards DH; Griffith TM
Br J Pharmacol; 1992 Jun; 106(2):348-53. PubMed ID: 1327377
[TBL] [Abstract][Full Text] [Related]
23. Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.
Néant F; Imbert-Teboul M; Bailly C
J Clin Invest; 1994 Sep; 94(3):1156-62. PubMed ID: 7521885
[TBL] [Abstract][Full Text] [Related]
24. Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers.
Westendorp RG; Draijer R; Meinders AE; van Hinsbergh VW
J Vasc Res; 1994; 31(1):42-51. PubMed ID: 7903872
[TBL] [Abstract][Full Text] [Related]
25. Effects of atrial natriuretic peptide and sodium nitroprusside on epidermal growth factor-stimulated wound repair in rabbit corneal epithelial cells.
Zhang Y; Islam M; Akhtar RA
Curr Eye Res; 2000 Sep; 21(3):748-56. PubMed ID: 11120563
[TBL] [Abstract][Full Text] [Related]
26. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.
Kaufmann JE; Oksche A; Wollheim CB; Günther G; Rosenthal W; Vischer UM
J Clin Invest; 2000 Jul; 106(1):107-16. PubMed ID: 10880054
[TBL] [Abstract][Full Text] [Related]
27. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
28. The involvement of products of the phospholipase pathway in the acute release of tissue-type plasminogen activator from perfused rat hindlegs.
Tranquille N; Emeis JJ
Eur J Pharmacol; 1992 Mar; 213(2):285-92. PubMed ID: 1521562
[TBL] [Abstract][Full Text] [Related]
29. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium.
Newby DE; Wright RA; Ludlam CA; Fox KA; Boon NA; Webb DJ
Thromb Haemost; 1997 Oct; 78(4):1242-8. PubMed ID: 9364992
[TBL] [Abstract][Full Text] [Related]
30. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
31. Evidence that spontaneous contractile activity in the rat myometrium is not inhibited by NO-mediated increases in tissue levels of cyclic GMP.
Hennan JK; Diamond J
Br J Pharmacol; 1998 Mar; 123(5):959-67. PubMed ID: 9535026
[TBL] [Abstract][Full Text] [Related]
32. Cardiac sympathetic nerve stimulation triggers coronary t-PA release.
Björkman JA; Jern S; Jern C
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1091-7. PubMed ID: 12714432
[TBL] [Abstract][Full Text] [Related]
33. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation.
Brunner F; Wölkart G
Microvasc Res; 2001 Jan; 61(1):102-10. PubMed ID: 11162200
[TBL] [Abstract][Full Text] [Related]
34. Motor responses in rat ileum evoked by nitric oxide donors vs. field stimulation: modulation by pituitary adenylate cyclase-activating peptide, forskolin and guanylate cyclase inhibitors.
Ekblad E; Sundler F
J Pharmacol Exp Ther; 1997 Oct; 283(1):23-8. PubMed ID: 9336304
[TBL] [Abstract][Full Text] [Related]
35. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
36. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
37. Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor from endothelial cells.
Rondaij MG; Sellink E; Gijzen KA; ten Klooster JP; Hordijk PL; van Mourik JA; Voorberg J
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1315-20. PubMed ID: 15130921
[TBL] [Abstract][Full Text] [Related]
38. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
39. Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6.
Newby DE; Stewart A; Witherow FN; Grieve S; Dawson P; Fox KA; Webb DJ; Ludlam CA
Thromb Haemost; 2000 Aug; 84(2):195-203. PubMed ID: 10959689
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological stimulation of t-PA release.
Klöcking HP; Markwardt F
Pharmazie; 1994 Apr; 49(4):227-30. PubMed ID: 7910971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
